Prevalence of hormone prescription and education for cis and trans women by medical trainees by Meister, Madison T et al.
University of Louisville 
ThinkIR: The University of Louisville's Institutional Repository 
Undergraduate Research Events Undergraduate Research 
Fall 9-2020 
Prevalence of hormone prescription and education for cis and 
trans women by medical trainees 
Madison T Meister 
University of Louisville 
Laura A. Weingartner 
University of Louisville 
Emily J. Noonan 
University of Louisville 
Follow this and additional works at: https://ir.library.louisville.edu/undergradresearch 
 Part of the Medical Education Commons 
Recommended Citation 
Meister, Madison T; Weingartner, Laura A.; and Noonan, Emily J., "Prevalence of hormone prescription and 
education for cis and trans women by medical trainees" (2020). Undergraduate Research Events. 18. 
https://ir.library.louisville.edu/undergradresearch/18 
This Poster is brought to you for free and open access by the Undergraduate Research at ThinkIR: The University of 
Louisville's Institutional Repository. It has been accepted for inclusion in Undergraduate Research Events by an 
authorized administrator of ThinkIR: The University of Louisville's Institutional Repository. For more information, 
please contact thinkir@louisville.edu. 
• LGBTQ+ patients experience a disproportionate 
number of barriers to healthcare and trans patients 
experience discrimination due to gender identity1
• Transgender patients may take hormones to affirm 
their gender identity, such as feminizing gender-
affirming hormones (estrogen) taken by some 
transgender women2
• Studying how trainees discuss the risks of 
hormones for both cis and trans women can 
demonstrate if disparities exist and how we may 
address them to overcome the multitude of 
healthcare barriers these patients report3
ResultsIntroduction
Methods
• Interviews were conducted by third year medical 
students with standardized patients in a primary 
care setting with a new patient to establish care
• 50 videos were analyzed with patients who were 
cis women (n= 28) and trans women (n=22)
• Each patient was trained to report use of estrogen 
patches they had purchased online for acne 
control (cis) or gender-affirming (trans) purposes
• Each patient asked the student for a prescription
• Students had previously completed LGBTQ 
clinical skills training in which estrogen would be 
appropriate for trans women, while students would 
be expected to be recommended a combination 
estrogen/progestin contraceptive to cis women.
• This study was approved by the University of 
Louisville Institutional Review Board.
• Students in this study were willing to prescribe 
estrogen to trans women 
• Our findings suggest that LGBTQ clinical skills 
training may prime students to be able and willing to 
prescribe hormones for gender-affirming care in a 
primary care setting
• Our findings also show that the majority of students 
discussed hormone health risks with their patients, 
regardless of gender identity
• One limitation of this study is that our analysis did not 
separate the risk discussions by the type of hormones 
for cis women (unopposed estrogen v. combination 
estrogen/progestin oral contraceptive), which may 
artificially inflate risk discussions that cis women 
would typically encounter relative to trans women 
• Follow-up studies should compare risk discussions 
among trans women seeking estrogen and cis women 
seeking oral contraceptives 
• Future studies could also compare rates of hormone 
prescription and risk discussions among students who 
have not had similar LGBTQ clinical skills training
Discussion
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Objectives
The purpose of this study was to investigate:
• A comparison of the rate at which cis women and 
trans women are prescribed hormones
• The prevalence of hormone health risk 
discussions by medical trainees
• Students agreed to prescribe hormones 
more frequently to patients who identified as 
trans women than cis women (Figure1)
• Of the 90% (n=43) of students who agreed 
to prescribe hormones, 47% (n=20) 
prescribed it conditionally, including: pending 
lab results, students desire to research 
hormones, or checking with their attendings 
• Three students who did not agree to 
prescribe hormones referred the patient to 
dermatology, OBGYN, or endocrinology 
• Students discussed their personal 
knowledge prescribing hormones at similar 
rates among the trans and cis women 
(Figure 2)
• A majority of students discussed hormone 
health risks with patients (Figure 2)
• Many students wanted to prescribe different 
hormones (ex: oral contraceptives) or do 
more research on the topic (Figure 3)
• Of the total encounters where risks were 
discussed (n=42), 69% (n=29) were 
informative and 6% (n=4) were
condescending (all with cis patients)
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Figure 1: Hormone Prescription Rates for Cis and Trans Women
Figure 2: Frequency of Personal Knowledge and Risk Discussions
Medication Risks:
“Uncontrolled estrogen can have 
adverse long-term side effects, such as 
increasing your risk for cancers.”
Delayed Prescription:
“I would have to do some research, but 
I would like to prescribe them for you.”
Informative Discussion:
“There are a lot of hormone delivery 
methods we could use to get the results 
you want.”
Distribution Risks: 
“Taking hormones that you order online 
can have a number of side effects.”
Alternatives for Cis Women:
“I would really like to prescribe an oral 
contraceptive instead of just estrogen.”
Condescending Discussion:
“Just because it worked for your friend 
doesn’t mean it will work for you.”
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